Oslo University Hospital
Oslo, Norway
64 recruiting
Showing 1–20 of 156 trials
Recruiting
Phase 3
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Endometrial Cancer
BioNTech SE480 enrolled171 locationsNCT06340568
Recruiting
Phase 2
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Endometrial Cancer
Canadian Cancer Trials Group393 enrolled114 locationsNCT05640999
Recruiting
Phase 2
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Advanced Systemic Mastocytosis (AdvSM)SM With an Associated Hematologic Neoplasm (SM-AHN)Mast Cell Leukemia (MCL)+1 more
Cogent Biosciences, Inc.140 enrolled42 locationsNCT04996875
Recruiting
Prospective Natural History Study of POLG Disease
PolG, Primary Mitochondrial Myopathy
The POLG Foundation300 enrolledNCT07775872
Recruiting
Phase 3
Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer
Prostate Cancer
Sven Löffeler980 enrolled18 locationsNCT05448547
Recruiting
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
Retinitis PigmentosaInherited Retinal Degeneration
Jaeb Center for Health Research1,500 enrolled36 locationsNCT05589714
Recruiting
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Bladder CancerNon Muscle Invasive Bladder Cancer
Photocure500 enrolled4 locationsNCT07144319
Recruiting
Phase 2Phase 3
Visugromab in Cachexia International Trial
Cancer-associated Cachexia
CatalYm GmbH518 enrolled56 locationsNCT07112196
Recruiting
Phase 3
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Crohn's Disease
Janssen Research & Development, LLC120 enrolled85 locationsNCT05923073
Recruiting
Phase 3
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1Impaired Hypoglycemic AwarenessSevere Hypoglycemia
Vertex Pharmaceuticals Incorporated57 enrolled29 locationsNCT04786262
Recruiting
Not Applicable
Skin Microcirculation in Patients With Lower Limb Atherosclerosis
Percutaneous Transluminal AngioplastyAtherosclerosis of Arteries of the Extremities, Unspecified
ODI Medical AS30 enrolled1 locationNCT07312383
Recruiting
Phase 3
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Crohn's Disease
Eli Lilly and Company90 enrolled81 locationsNCT05509777
Recruiting
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
Aortic Valve Stenosis
The Leeds Teaching Hospitals NHS Trust550 enrolled71 locationsNCT06557798
Recruiting
Phase 1
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms
Eli Lilly and Company677 enrolled82 locationsNCT05614739
Recruiting
Phase 3
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Gilead Sciences695 enrolled218 locationsNCT06801834
Recruiting
Cerebellar Mutism Syndrome Study
Infratentorial NeoplasmsMutism
Rigshospitalet, Denmark2,000 enrolled30 locationsNCT02300766
Recruiting
Phase 3
PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia
Preeclampsia
Lina Bergman294 enrolled17 locationsNCT06033131
Recruiting
Phase 2Phase 3
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Indolent Systemic MastocytosisSmoldering Systemic Mastocytosis
Blueprint Medicines Corporation534 enrolled71 locationsNCT04910685
Recruiting
Phase 1Phase 2
Bortezomib and Temozolomide in Recurrent Grade-4 Glioma Unmethylated MGMT Promoter (BORTEM-17)
Glioblastoma
Haukeland University Hospital63 enrolledNCT03643549
Recruiting
DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
Liver CancerLiver Metastases
Maastricht University Medical Center350 enrolled31 locationsNCT07717437